Supervisor Elham AbolFateh
Editor in Chief Mohamed Wadie

H&M Provides Social Media Access to Global Aid Orgs. to Combat Covid-19


Fri 27 Mar 2020 | 09:42 AM
Yara Sameh

Swedish multinational clothing-retail company H&M is offering money, personal protective equipment, and social networks access to those on the coronavirus outbreak's front lines.

The Swedish retail giant donated $500,000 to the COVID-19 Solidarity Response Fund; it was launched on March 13 by the UN Foundation, the Swiss Philanthropy Foundation, and the World Health Organization to help countries, especially the vulnerable ones to combat the global pandemic.

New York Post reported that H&M is also offering access to its social media channels — which have 120 million followers in total — to global aid organizations such as the Red Cross, which will enable them to provide vital public health alerts and guidance during the pandemic.

H&M Group is also producing personal protective equipment for healthcare providers worldwide.

It is worth mentioning that the World Health Organization (WHO) declared coronavirus a global pandemic on March 11 as the new virus has rapidly spread to more than 121,000 people from Asia to the Middle East, Europe, and the United States.

More cases of the virus, which causes respiratory disease Covid-19, continue to emerge, with outbreaks in South Korea, Italy, and Iran.

The data collected so far showed that at least 533,015 people are infected and about 24,095 people have died.

Transmission of viruses between humans happens when someone comes into contact with an infected person’s secretions, such as droplets in a cough.

They can also be transmitted by coming into contact with something an infected person has touched and then touching your mouth, nose or eyes.

It is known that older people appear to be more vulnerable to the effects of the emerging virus.

People across the globe partake in self-isolation for 14 days as an effective precautionary measure to protect those around them and themselves from contracting COVID-19.